SHZ · 000963.SZ
Huadong Medicine Co., Ltd
CN¥26.61+CN¥0.73 (+2.82%)
Huadong Medicine Co., Ltd’s quoted price sits in the lower half of its reported 52-week range, 39.22% below the high.
Loading market information…
SHZ · 002755.SZ · CNY
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 04:56 AM UTC. Cached market data; not a live quote.
One-year closing-price history · CNY. Historical prices are not a forecast.
Beijing Aosaikang Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 40.53% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Beijing Aosaikang Pharmaceutical Co., Ltd.’s forward annual dividend is CN¥0.12 per share, paid annual. The forward yield is 1.0% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Beijing Aosaikang Pharmaceutical Co., Ltd.’s next earnings report is currently expected on Apr 26, 2027. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Beijing Aosaikang Pharmaceutical Co., Ltd.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Operating within China, Beijing Aosaikang Pharmaceutical Co., Ltd. specializes in the research, development, production, and sale of pharmaceuticals, fine chemicals, and health products. Its diverse offerings include proton pump inhibitor injections, oncology medications, and active pharmaceutical ingredients (APIs), which are applied across key therapeutic areas like digestive disorders, cancer treatment, and infectious diseases. The company was founded in 2003 and is headquartered in Nanjing, China.
Latest available per-share figures in CNY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:12 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| CN¥393.19M |
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CN¥26.61+CN¥0.73 (+2.82%)
Huadong Medicine Co., Ltd’s quoted price sits in the lower half of its reported 52-week range, 39.22% below the high.
CN¥23.67+CN¥0.04 (+0.17%)
Guangdong Zhongsheng Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 30.93% below the high.
CN¥15.36+CN¥0.19 (+1.25%)
China Resources Double-Crane Pharmaceutical Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 22.31% below the high.
CN¥13.23+CN¥0.51 (+4.01%)
Zhejiang Hisun Pharmaceutical Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 11.8% below the high.
CN¥73.80+CN¥0.75 (+1.03%)
Fujian Cosunter Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 50.47% below the high.
CN¥15.02+CN¥0.52 (+3.59%)
Guobang Pharma Ltd.’s quoted price sits in the lower half of its reported 52-week range, 29.86% below the high.
CN¥8.13+CN¥0.07 (+0.87%)
Shanghai Shyndec Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 26.69% below the high.
CN¥11.28+CN¥0.22 (+1.99%)
Zhejiang Jingxin Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 47.9% below the high.
